Get started
Author

Ioannis Kotsantis

Prognostic significance of PD-L1 expression on circulating tumor cells in patients with head and neck squamous cell carcinoma
2017 · A. Strati, G. Koutsodontis, et al. · Annals of Oncology · 204
Diagnostic Tumor Markers in Head and Neck Squamous Cell Carcinoma (HNSCC) in the Clinical Setting
2019 · Panagiota Economopoulou, Remco de Bree, et al. · Frontiers in Oncology · 193
PDF
Medical management of gastric cancer: a 2017 update
2017 · Nikolaos Charalampakis, Panagiota Economopoulou, et al. · Cancer Medicine · 180
PDF
Airborne hydrogen peroxide for disinfection of the hospital environment and infection control: a systematic review
2011 · M.E. Falagas, P.C. Thomaidis, et al. · Journal of Hospital Infection · 159
Antibiotics versus placebo in the treatment of women with uncomplicated cystitis: A meta-analysis of randomized controlled trials
2009 · Matthew E. Falagas, Ioannis K. Kotsantis, et al. · Journal of Infection · 136
Special Issue about Head and Neck Cancers: HPV Positive Cancers
2020 · Panagiota Economopoulou, Ioannis Kotsantis, et al. · International Journal of Molecular Sciences · 68
PDF
Systematic Review of Recurrent Osteosarcoma Systemic Therapy
2021 · Ioanna Gazouli, Anastasios Kyriazoglou, et al. · Cancers · 67
PDF
Liquid biopsy: An emerging prognostic and predictive tool in Head and Neck Squamous Cell Carcinoma (HNSCC). Focus on Circulating Tumor Cells (CTCs)
2017 · P. Economopoulou, I. Kotsantis, et al. · Oral Oncology · 64
The promise of immunotherapy in head and neck squamous cell carcinoma: combinatorial immunotherapy approaches
2016 · Panagiota Economopoulou, Ioannis Kotsantis, et al. · ESMO Open · 63
The Role of CXCL13 and CXCL9 in Early Breast Cancer
2019 · Evangelia Razis, Konstantine T. Kalogeras, et al. · Clinical Breast Cancer · 57
B-cell infiltration is associated with survival outcomes following programmed cell death protein 1 inhibition in head and neck squamous cell carcinoma
2023 · N. Gavrielatou, E. Fortis, et al. · Annals of Oncology · 54
PDF
Tumor Microenvironment and Immunotherapy Response in Head and Neck Cancer
2020 · Panagiota Economopoulou, Ioannis Kotsantis, et al. · Cancers · 50
PDF
Targeting the PD-1/PD-L1 Signaling Pathway for Cancer Therapy: Focus on Biomarkers
2025 · Areti Strati, Christos Adamopoulos, et al. · International Journal of Molecular Sciences · 46
PDF
The DNA damage response network in the treatment of head and neck squamous cell carcinoma
2021 · A. Psyrri, M. Gkotzamanidou, et al. · ESMO Open · 44
PDF
Overcoming Resistance to Temozolomide in Glioblastoma: A Scoping Review of Preclinical and Clinical Data
2024 · Dimitra Smerdi, Myrto Moutafi, et al. · Life · 34
De-Escalating Strategies in HPV-Associated Head and Neck Squamous Cell Carcinoma
2021 · Panagiota Economopoulou, Ioannis Kotsantis, et al. · Viruses · 31
PDF
Prognostic impact of indoleamine 2,3-dioxygenase 1 (IDO1) mRNA expression on circulating tumour cells of patients with head and neck squamous cell carcinoma
2020 · Panagiota Economopoulou, Athina Kladi-Skandali, et al. · ESMO Open · 29
Patterns of Response to Immune Checkpoint Inhibitors in Association with Genomic and Clinical Features in Patients with Head and Neck Squamous Cell Carcinoma (HNSCC)
2021 · Panagiota Economopoulou, Maria Anastasiou, et al. · Cancers · 28
HPV16 E6/E7 expression in circulating tumor cells in oropharyngeal squamous cell cancers: A pilot study
2019 · Panagiota Economopoulou, George Koutsodontis, et al. · PLoS ONE · 28
PDF
Phase II Window Study of Olaparib Alone or with Cisplatin or Durvalumab in Operable Head and Neck Cancer
2023 · Myrto Moutafi, Georgia-Angeliki Koliou, et al. · Cancer Research Communications · 27
PDF
Next-generation sequencing (NGS) profiling of matched tumor and circulating tumor DNA (ctDNA) in head and neck squamous cell carcinoma (HNSCC)
2023 · Panagiota Economopoulou, Aris Spathis, et al. · Oral Oncology · 27
Tyrosine kinase inhibitors in sarcoma treatment (Review)
2022 · Anastasios Kyriazoglou, Lydia Gkaralea, et al. · Oncology Letters · 27
PDF
Lymph Node Ratio as a Prognostic Factor in Neck Dissection in Oral Cancer Patients: A Systematic Review and Meta-Analysis
2022 · Zoi Gartagani, Stergios Doumas, et al. · Cancers · 26
PDF
Immune checkpoint inhibitors in sarcomas: a systematic review
2023 · M. Anastasiou, A. Kyriazoglou, et al. · Immuno-Oncology Technology · 25
PDF
Checkpoint Inhibitors in Head and Neck Cancer: Rationale, Clinical Activity, and Potential Biomarkers
2016 · Panagiota Economopoulou, Ioannis Kotsantis, et al. · Current Treatment Options in Oncology · 24
Works count: 126
Citation count: 2,013
H-index: 24
I10-index: 40
Year
Topic
Type